Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.4.3.13 (
lysyl oxidase
)
1,248
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Various o- and p-quinones were assessed as oxidants of peptidyl lysine in elastin and collagen substrates in the presence and absence of divalent copper as paradigms of
protein-lysine 6-oxidase
(
lysyl oxidase
) which contains both quinone and copper cofactors. Pyrroloquinoline quinone was among the most active in the absence and the most active of the o- and p-quinones tested in the presence of copper. The optimal rate of elastin oxidation occurred at a 2:1 PQQ/Cu(II) ratio while Cu(II) itself oxidized elastin relatively slightly. Elastin oxidation by 2:1 PQQ/Cu(II) required aerobic conditions consistent with oxygen-dependent turnover of this catalytic pair. Dimethylsulfoxide and
catalase
individually or in combination inhibited elastin oxidation by PQQ/Cu(II) by approx. 50%, suggesting that oxygen free radical species participate in the reaction. Amino-acid analysis of elastin and collagen substrates oxidized by 2:1 PQQ/Cu and then reduced with borohydride revealed that alpha-aminoadipic-delta-semialdehyde and lesser amounts of covalent cross-linkages were generated by this oxidant. In contrast, lysine oxidase produced aldehydes and significantly greater quantities of cross-linkage products, consistent with the known specificity of the enzyme. These data, thus, indicate the potential for free quinones, such as PQQ, particularly when stimulated by appropriate metal ions, to act as adventitious oxidants of lysine side-chains in proteins.
...
PMID:Oxidation of peptidyl lysine by copper complexes of pyrroloquinoline quinone and other quinones. A model for oxidative pathochemistry. 132 61
Exposure of [3H]-lysine labeled elastin to either purified myeloperoxidase plus H2O2 and halides or human neutrophils plus phorbol myristate acetate resulted in oxidation of lysine side chains quantitated as 3H2O release. In both the enzyme and cell system oxidation was blocked by azide, cyanide or
catalase
, but not by beta-aminopropionitrile, an inhibitor of
lysyl oxidase
. Myeloperoxidase-deficient neutrophils were ineffective unless exogenous myeloperoxidase was added. These data provide a biochemical basis for inflammatory changes in connective tissue proteins mediated by oxidant secretory products of neutrophils.
...
PMID:Oxidation of lysine side-chains of elastin by the myeloperoxidase system and by stimulated human neutrophils. 300 20
The activity of
lysyl oxidase
was found in egg shell membrane (ESM) of hens. The activity was determined by measuring the enzymatic conversion of n-butylamine and Nalpha-acetyl-L-lysine to n-butyraldehyde and Nalpha-acetyl-L-allysine, respectively. ESM
lysyl oxidase
was significantly inhibited by beta-aminopropionitrile, chelating agents, and deoxygenation, consistent with the known properties of
lysyl oxidase
. Nevertheless, ESM
lysyl oxidase
was insoluble in urea solution, suggesting that it complexes with ESM. These findings support previous reports indicating the presence of lysine-derived cross-links in ESM and the necessity of
lysyl oxidase
located in the isthmus of the hen oviduct for the biosynthesis of ESM. Lysyl oxidase secreted around the egg white from the isthmus may initiate the cross-linking reaction of ESM protein, and remain as the constituent of ESM. Moreover, the H(2)O(2) released by
lysyl oxidase
in ESM was completely decomposed by coexisting
catalase
activity. ESM
lysyl oxidase
activity was greatly elevated in the presence of H(2)O(2), probably due to the O(2) produced by
catalase
. These findings indicate that
lysyl oxidase
is coupled with
catalase
in ESM. This coupling enzyme system was considered to be involved in the biosynthesis of ESM and to protect the embryo against H(2)O(2).
...
PMID:Lysyl oxidase coupled with catalase in egg shell membrane. 1055 69
We have previously shown that
lysyl oxidase
(
LOX
) mRNA is up-regulated in invasive breast cancer cells and that catalytically active
LOX
facilitates in vitro cell invasion. Here we validate our in vitro studies by showing that
LOX
expression is up-regulated in distant metastatic breast cancer tissues compared with primary cancer tissues. To elucidate the mechanism by which
LOX
facilitates cell invasion, we show that catalytically active
LOX
regulates in vitro motility/migration and cell-matrix adhesion formation. Treatment of the invasive breast cancer cell lines, Hs578T and MDA-MB-231, with beta-aminopropionitrile (betaAPN), an irreversible inhibitor of
LOX
catalytic activity, leads to a significant decrease in cell motility/migration and adhesion formation. Conversely, poorly invasive MCF-7 cells expressing
LOX
(MCF-7/LOX32-His) showed an increase in migration and adhesion that was reversible with the addition of betaAPN. Moreover, a decrease in activated focal adhesion kinase (FAK) and Src kinase, key proteins involved in adhesion complex turnover, was observed when invasive breast cancer cells were treated with betaAPN. Additionally, FAK and Src activation was increased in MCF-7/LOX32-His cells, which was reversible on betaAPN treatment. Hydrogen peroxide was produced as a by-product of
LOX
activity and the removal of hydrogen peroxide by
catalase
treatment in invasive breast cancer cells led to a dose-dependent loss in Src activation. These results suggest that
LOX
facilitates migration and cell-matrix adhesion formation in invasive breast cancer cells through a hydrogen peroxide-mediated mechanism involving the FAK/Src signaling pathway. These data show the need to target
LOX
for treatment of aggressive breast cancer.
...
PMID:Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. 1635 51
The extracellular matrix (ECM) plays a critical role during the development and invasion of primary brain tumours. However, the function of ECM components and signalling between a permissive ECM and invasive astrocytes is not fully understood. We have recently reported the ECM enzyme,
lysyl oxidase
(
LOX
), in the central nervous system and observed up-regulation of
LOX
in anaplastic astrocytoma cells. While the catalytic function of
LOX
is essential for cross-linking of ECM proteins, we also reported that
LOX
induced invasive and metastatic properties in breast tumour epithelial cells through hydrogen peroxide-mediated FAK/Src activation. In this study, we tested the hypothesis that active
LOX
is expressed in anaplastic astrocytes and promotes FAK activation and invasive/migratory behaviour. Results demonstrate that increased expression and activity of
LOX
positively correlated with invasive phenotype of malignant astrocytoma cell lines. Immunohistochemistry detected increased
LOX
within tumour cells and ECM in grade I-IV astrocytic neoplasm compared with normal brain and coincidence of increased
LOX
with the loss of glial fibrillary acidic protein in higher-grade tumours. Increased active
LOX
in invasive astrocytes was accompanied by phosphorylation of FAK[Tyr576] and paxillin[Tyr118]; furthermore, both FAK and paxillin tyrosine phosphorylation were diminished by beta-aminopropionitrile inhibition of
LOX
activity and depletion of H(2)O(2) via
catalase
treatment. Additionally, we provide evidence that in astrocytes,
LOX
is likely processed by bone morphogenic protein-1 and
LOX
activity might be further stimulated by the expression of fibronectin in these cells. These results demonstrate an important
LOX
-mediated mechanism that promotes migratory/invasive behaviour of malignant astrocytes.
...
PMID:Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes. 1793 58
The effects of the alcoholic extract of the flowers ofIxora coccinea were studied on some of the antioxidant enzymes in dead space wounds created in rats. Increases in the tensile strength of the wound and in the level of
lysyl oxidase
, the crucial enzyme for collagen maturation, were observed indicating a definite prohealing action. In addition, a highly significant increase in the levels of
catalase
, glutathione peroxidase and glutathione reductase was observed in the drug-treated group. Thus, the gain in tensile strength may be attributed not only to the better cross-linking but also to the antioxidant properties of the drug.
...
PMID:Altered antioxidant enzyme profile in wound healing. 2310 75